Global TravEpiNet

A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

Regina C. Larocque, Sowmya R. Rao, Jennifer Lee, Vernon Ansdell, Johnnie A. Yates, Brian S. Schwartz, Mark Knouse, John Cahill, Stefan Hagmann, Joseph Vinetz, Bradley A. Connor, Jeffery A. Goad, Alawode Oladele, Salvador Alvarez, William Stauffer, Patricia Walker, Phyllis Kozarsky, Carlos Franco-Paredes, Roberta Dismukes, Jessica Rosen & 12 others Noreen A. Hynes, Frederique Jacquerioz, Susan McLellan, Devon Hale, Theresa Sofarelli, David Schoenfeld, Nina Marano, Gary Brunette, Emily S. Jentes, Emad Yanni, Mark J. Sotir, Edward T. Ryan

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

Original languageEnglish (US)
Pages (from-to)455-462
Number of pages8
JournalClinical Infectious Diseases
Volume54
Issue number4
DOIs
StatePublished - Feb 15 2012
Externally publishedYes

Fingerprint

Demography
Delivery of Health Care
Yellow Fever
Hepatitis A
Typhoid Fever
Health
Antimalarials
Risk Reduction Behavior
Population
Malaria
Communicable Diseases
Diarrhea
Vaccination
Referral and Consultation
Vaccines
Anti-Bacterial Agents
Infection
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Global TravEpiNet : A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. / Larocque, Regina C.; Rao, Sowmya R.; Lee, Jennifer; Ansdell, Vernon; Yates, Johnnie A.; Schwartz, Brian S.; Knouse, Mark; Cahill, John; Hagmann, Stefan; Vinetz, Joseph; Connor, Bradley A.; Goad, Jeffery A.; Oladele, Alawode; Alvarez, Salvador; Stauffer, William; Walker, Patricia; Kozarsky, Phyllis; Franco-Paredes, Carlos; Dismukes, Roberta; Rosen, Jessica; Hynes, Noreen A.; Jacquerioz, Frederique; McLellan, Susan; Hale, Devon; Sofarelli, Theresa; Schoenfeld, David; Marano, Nina; Brunette, Gary; Jentes, Emily S.; Yanni, Emad; Sotir, Mark J.; Ryan, Edward T.

In: Clinical Infectious Diseases, Vol. 54, No. 4, 15.02.2012, p. 455-462.

Research output: Contribution to journalArticle

Larocque, RC, Rao, SR, Lee, J, Ansdell, V, Yates, JA, Schwartz, BS, Knouse, M, Cahill, J, Hagmann, S, Vinetz, J, Connor, BA, Goad, JA, Oladele, A, Alvarez, S, Stauffer, W, Walker, P, Kozarsky, P, Franco-Paredes, C, Dismukes, R, Rosen, J, Hynes, NA, Jacquerioz, F, McLellan, S, Hale, D, Sofarelli, T, Schoenfeld, D, Marano, N, Brunette, G, Jentes, ES, Yanni, E, Sotir, MJ & Ryan, ET 2012, 'Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011', Clinical Infectious Diseases, vol. 54, no. 4, pp. 455-462. https://doi.org/10.1093/cid/cir839
Larocque, Regina C. ; Rao, Sowmya R. ; Lee, Jennifer ; Ansdell, Vernon ; Yates, Johnnie A. ; Schwartz, Brian S. ; Knouse, Mark ; Cahill, John ; Hagmann, Stefan ; Vinetz, Joseph ; Connor, Bradley A. ; Goad, Jeffery A. ; Oladele, Alawode ; Alvarez, Salvador ; Stauffer, William ; Walker, Patricia ; Kozarsky, Phyllis ; Franco-Paredes, Carlos ; Dismukes, Roberta ; Rosen, Jessica ; Hynes, Noreen A. ; Jacquerioz, Frederique ; McLellan, Susan ; Hale, Devon ; Sofarelli, Theresa ; Schoenfeld, David ; Marano, Nina ; Brunette, Gary ; Jentes, Emily S. ; Yanni, Emad ; Sotir, Mark J. ; Ryan, Edward T. / Global TravEpiNet : A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. In: Clinical Infectious Diseases. 2012 ; Vol. 54, No. 4. pp. 455-462.
@article{fc45f1d258d749c0a4087f288f0faa23,
title = "Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011",
abstract = "Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38{\%} were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.",
author = "Larocque, {Regina C.} and Rao, {Sowmya R.} and Jennifer Lee and Vernon Ansdell and Yates, {Johnnie A.} and Schwartz, {Brian S.} and Mark Knouse and John Cahill and Stefan Hagmann and Joseph Vinetz and Connor, {Bradley A.} and Goad, {Jeffery A.} and Alawode Oladele and Salvador Alvarez and William Stauffer and Patricia Walker and Phyllis Kozarsky and Carlos Franco-Paredes and Roberta Dismukes and Jessica Rosen and Hynes, {Noreen A.} and Frederique Jacquerioz and Susan McLellan and Devon Hale and Theresa Sofarelli and David Schoenfeld and Nina Marano and Gary Brunette and Jentes, {Emily S.} and Emad Yanni and Sotir, {Mark J.} and Ryan, {Edward T.}",
year = "2012",
month = "2",
day = "15",
doi = "10.1093/cid/cir839",
language = "English (US)",
volume = "54",
pages = "455--462",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Global TravEpiNet

T2 - A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

AU - Larocque, Regina C.

AU - Rao, Sowmya R.

AU - Lee, Jennifer

AU - Ansdell, Vernon

AU - Yates, Johnnie A.

AU - Schwartz, Brian S.

AU - Knouse, Mark

AU - Cahill, John

AU - Hagmann, Stefan

AU - Vinetz, Joseph

AU - Connor, Bradley A.

AU - Goad, Jeffery A.

AU - Oladele, Alawode

AU - Alvarez, Salvador

AU - Stauffer, William

AU - Walker, Patricia

AU - Kozarsky, Phyllis

AU - Franco-Paredes, Carlos

AU - Dismukes, Roberta

AU - Rosen, Jessica

AU - Hynes, Noreen A.

AU - Jacquerioz, Frederique

AU - McLellan, Susan

AU - Hale, Devon

AU - Sofarelli, Theresa

AU - Schoenfeld, David

AU - Marano, Nina

AU - Brunette, Gary

AU - Jentes, Emily S.

AU - Yanni, Emad

AU - Sotir, Mark J.

AU - Ryan, Edward T.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

AB - Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

UR - http://www.scopus.com/inward/record.url?scp=84863068669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863068669&partnerID=8YFLogxK

U2 - 10.1093/cid/cir839

DO - 10.1093/cid/cir839

M3 - Article

VL - 54

SP - 455

EP - 462

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -